PubMed

Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.

Kobayashi J, Torigoe T, Hirohashi Y, Idenoue S, Miyazaki A, Yamaguchi A, Hiratsuka H, Sato N.

J Transl Med. 2009 Jan 6;7:1.PMID: 19123955 [PubMed - indexed for MEDLINE]Related articlesFree article

An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.

Hirohashi Y, Torigoe T, Maeda A, Nabeta Y, Kamiguchi K, Sato T, Yoda J, Ikeda H, Hirata K, Yamanaka N, Sato N.

Clin Cancer Res. 2002 Jun;8(6):1731-9.PMID: 12060610 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.

Yamaguchi H, Tanaka F, Ohta M, Inoue H, Mori M.

Clin Cancer Res. 2004 Feb 1;10(3):890-6.PMID: 14871964 [PubMed - indexed for MEDLINE]Related articlesFree article

A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins.

Idenoue S, Hirohashi Y, Torigoe T, Sato Y, Tamura Y, Hariu H, Yamamoto M, Kurotaki T, Tsuruma T, Asanuma H, Kanaseki T, Ikeda H, Kashiwagi K, Okazaki M, Sasaki K, Sato T, Ohmura T, Hata F, Yamaguchi K, Hirata K, Sato N.

Clin Cancer Res. 2005 Feb 15;11(4):1474-82.PMID: 15746049 [PubMed - indexed for MEDLINE]Related articlesFree article

Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs.

Mimura K, Kono K, Southwood S, Fikes J, Takahashi A, Miyagawa N, Sugai H, Fujii H.

Cancer Immunol Immunother. 2006 Nov;55(11):1358-66. Epub 2006 Jan 25.PMID: 16435129 [PubMed - indexed for MEDLINE]Related articles

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.

Schmidt SM, Schag K, Müller MR, Weck MM, Appel S, Kanz L, Grünebach F, Brossart P.

Blood. 2003 Jul 15;102(2):571-6. Epub 2003 Feb 6.PMID: 12576330 [PubMed - indexed for MEDLINE]Related articlesFree article

Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.

Hariu H, Hirohashi Y, Torigoe T, Asanuma H, Hariu M, Tamura Y, Aketa K, Nabeta C, Nakanishi K, Kamiguchi K, Mano Y, Kitamura H, Kobayashi J, Tsukahara T, Shijubo N, Sato N.

Clin Cancer Res. 2005 Feb 1;11(3):1000-9.PMID: 15709165 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.

Akiyama Y, Maruyama K, Mochizuki T, Sasaki K, Takaue Y, Yamaguchi K.

Immunol Lett. 2002 Aug 1;83(1):21-30.PMID: 12057851 [PubMed - indexed for MEDLINE]Related articles

Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes in an HLA-A24 restricted manner.

Kontani K, Teramoto K, Ozaki Y, Fujita T, Tezuka N, Sawai S, Watanabe H, Fujino S, Yokomise H, Ohkubo I.

Int J Oncol. 2004 Dec;25(6):1537-42.PMID: 15547688 [PubMed - indexed for MEDLINE]Related articles

A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.

Miyagawa N, Kono K, Mimura K, Omata H, Sugai H, Fujii H.

Oncology. 2006;70(1):54-62. Epub 2006 Jan 27.PMID: 16446550 [PubMed - indexed for MEDLINE]Related articles

Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.

Horiguchi Y, Nukaya I, Okazawa K, Kawashima I, Fikes J, Sette A, Tachibana M, Takesako K, Murai M.

Clin Cancer Res. 2002 Dec;8(12):3885-92.PMID: 12473604 [PubMed - indexed for MEDLINE]Related articlesFree article

Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.

Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.

Oncol Rep. 2004 Oct;12(4):725-31.PMID: 15375491 [PubMed - indexed for MEDLINE]Related articles

Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.

Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Itoh K, Yamada A.

Cell Immunol. 2006 May;241(1):38-46. Epub 2006 Sep 11.PMID: 16963008 [PubMed - indexed for MEDLINE]Related articles

Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals.

Karanikas V, Soukou F, Kalala F, Kerenidi T, Grammoustianou ES, Gourgoulianis KI, Germenis AE.

Clin Immunol. 2008 Nov;129(2):230-40. Epub 2008 Sep 13.PMID: 18789878 [PubMed - indexed for MEDLINE]Related articles

Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.

Morishima S, Akatsuka Y, Nawa A, Kondo E, Kiyono T, Torikai H, Nakanishi T, Ito Y, Tsujimura K, Iwata K, Ito K, Kodera Y, Morishima Y, Kuzushima K, Takahashi T.

Int J Cancer. 2007 Feb 1;120(3):594-604.PMID: 17096336 [PubMed - indexed for MEDLINE]Related articles

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.

Umano Y, Tsunoda T, Tanaka H, Matsuda K, Yamaue H, Tanimura H.

Br J Cancer. 2001 Apr 20;84(8):1052-7.PMID: 11308253 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.

Schmidt SM, Schag K, Müller MR, Weinschenk T, Appel S, Schoor O, Weck MM, Grünebach F, Kanz L, Stevanovic S, Rammensee HG, Brossart P.

Cancer Res. 2004 Feb 1;64(3):1164-70.PMID: 14871853 [PubMed - indexed for MEDLINE]Related articlesFree article

Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.

Kobayashi J, Hirohashi Y, Torigoe T, Michifuri Y, Yamamoto T, Tamura Y, Kamiguchi K, Miyazaki A, Yamaguchi A, Hariu H, Hiratsuka H, Sato N.

Hum Immunol. 2009 Feb;70(2):89-95. Epub 2009 Jan 3.PMID: 19124056 [PubMed - indexed for MEDLINE]Related articles

Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes.

Kikuchi M, Nakao M, Inoue Y, Matsunaga K, Shichijo S, Yamana H, Itoh K.

Int J Cancer. 1999 May 5;81(3):459-66.PMID: 10209962 [PubMed - indexed for MEDLINE]Related articles

A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.

Oiso M, Eura M, Katsura F, Takiguchi M, Sobao Y, Masuyama K, Nakashima M, Itoh K, Ishikawa T.

Int J Cancer. 1999 May 5;81(3):387-94.PMID: 10209953 [PubMed - indexed for MEDLINE]Related articles